A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media
Public ClinicalTrials.gov record NCT00645112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg every 12 hours for 5 days, to azithromycin oral suspension 10 mg/kg/day (Day 1) then 5 mg/kg/day (Days 2-5) for a total of 5 days, in children between 6 months and 6 years of age, with AOM.
Study identification
- NCT ID
- NCT00645112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 357 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months to 6 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Dec 31, 2003
- Completion
- Not listed
- Last update posted
- Mar 26, 2008
Started 2003
United States locations
- U.S. sites
- 30
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Columbiana | Alabama | 35051 | — |
| Not listed | Montgomery | Alabama | 36116 | — |
| Not listed | Ozark | Alabama | 36360 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Marietta | Georgia | 30062 | — |
| Not listed | Stone Mountain | Georgia | 30087 | — |
| Not listed | Dubuque | Iowa | 52002 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Louisville | Kentucky | 40207 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Cadillac | Michigan | 49601 | — |
| Not listed | Kalamazoo | Michigan | 49008 | — |
| Not listed | Portage | Michigan | 49024 | — |
| Not listed | Richland | Michigan | 49083 | — |
| Not listed | Omaha | Nebraska | 68178 | — |
| Not listed | Columbus | Ohio | 43205 | — |
| Not listed | Huber Heights | Ohio | 45424 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Reading | Pennsylvania | 19606 | — |
| Not listed | Sellersville | Pennsylvania | 18960 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Kingsport | Tennessee | 37664 | — |
| Not listed | Lake Jackson | Texas | 77566 | — |
| Not listed | Salt Lake City | Utah | 84109 | — |
| Not listed | Salt Lake City | Utah | 84121 | — |
| Not listed | West Jordan | Utah | 84008 | — |
| Not listed | West Jordan | Utah | 84084 | — |
| Not listed | Vienna | Virginia | 22180 | — |
| Not listed | Monroe | Wisconsin | 53566 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00645112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2008 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00645112 live on ClinicalTrials.gov.